Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Novel Screening Strategies for Scleroderma PAH

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by University of Michigan
Sponsor:
Information provided by (Responsible Party):
Scott Visovatti, MD, University of Michigan
ClinicalTrials.gov Identifier:
NCT01959815
First received: October 8, 2013
Last updated: October 17, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2018 (Final data collection date for primary outcome measure)